Astute Medical is dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers that can serve as the basis for novel diagnostic tests. The Company's focus is community and hospital acquired acute conditions that require rapid diagnosis and risk assessment. The Company's current areas of interest include abdominal pain, acute coronary syndromes, cerebrovascular injury, kidney injury and sepsis. Founded in 2007, the Company is led by Christopher Hibberd and Paul McPherson Ph.D., former members of the management at Biosite Incorporated, a leading diagnostics company acquired by Inverness Medical Innovations in 2007 for $1.7 billion. Hibberd served at Biosite for 10 years, most recently as Senior Vice President Corporate Development. Dr. McPherson was at Biosite for 14 years, most recently as Vice President Research and Development.
Type
Private
HQ
San Diego, US
Founded
2007
Size (employees)
67 (est)+2%
Astute Medical was founded in 2007 and is headquartered in San Diego, US
Report incorrect company information

Key People/Management at Astute Medical

Chris Hibberd

Chris Hibberd

CEO , Co-Founder & Board Member
W. Todd Myers

W. Todd Myers

CFO
Paul McPherson

Paul McPherson

Co-Founder , CSO & Board Member

Astute Medical Office Locations

Astute Medical has an office in San Diego
San Diego, US (HQ)
3550 General Atomics Ct
Show all (1)
Report incorrect company information

Astute Medical Financials and Metrics

Summary Metrics

Founding Date

2007

Total Funding

$164.2 m

Latest funding size

$43 m

Time since last funding

a year ago

Investors

Astute Medical's latest funding round in December 2016 was reported to be $43 m. In total, Astute Medical has raised $164.2 m
Report incorrect company information